RHI MAGNESITA INDIA LTD has informed the Exchange regarding Board meeting held on February 13, 2026.
RHIM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts more than Nifty Smallcap 250 and 6.5 pts more than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Standalone Q3 revenue from operations rose to Rs. 903 crore (up ~16.7% YoY from Rs. 774 crore) and 9M revenue grew ~20.3% YoY to Rs. 2,571 crore, driven by volume growth. However, standalone 9M profit after tax fell to Rs. 157 crore from Rs. 187 crore in 9M FY25, with EPS declining to Rs. 7.59 from Rs. 9.04, as other expenses surged sharply, squeezing margins. Consolidated 9M revenue rose to Rs. 3,088 crore (+12% YoY) but consolidated 9M PAT dropped to Rs. 135 crore from Rs. 166 crore. Price Waterhouse issued a clean, unmodified limited review report on both sets of results. Other highlights include the completed acquisition of Ashwath Technologies by subsidiary IEIPL in August 2025, the merger of erstwhile RHI Magnesita Seven Refractories with RHI Magnesita India Refractories effective Feb 2, 2026, and a one-time Rs. 71 lakh (standalone) / Rs. 554 lakh (consolidated) impact from new labour codes.
Positive on the topline (standalone 9M revenue crossed the 20% growth mark) but negative on profitability — margins compressed meaningfully despite higher sales, which is the main concern for shareholders. The clean audit and continued business expansion (Ashwath acquisition, subsidiary merger) provide some offset, but the cost-side pressure is the key story to watch in upcoming quarters.